India's pharma industry built its global reputation on manufacturing scale. Its next phase will be shaped by two forces: artificial intelligence and cybersecurity.
AI now speeds up drug discovery, predicts equipment failure and catches defects invisible to the human eye, turning pharma manufacturing genuinely intelligent.
Every connected system, from IIoT sensors to GCCs, expands the attack surface. A single breach can halt production or delay life-saving medicine.
Neither technology wins alone. AI without security is fragile, and security without AI limits growth. Together, they define India's next pharma advantage.